- Home
- DHF vs INGN Comparison
DHF vs INGN Comparison
Compare DHF & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DHF | INGN |
|---|---|---|
| Founded | N/A | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.9M | 177.1M |
| IPO Year | 1998 | 2013 |
Fundamental Metrics
Financial Performance| Metric | DHF | INGN |
|---|---|---|
| Price | $2.37 | $5.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $11.25 |
| AVG Volume (30 Days) | ★ 317.8K | 239.3K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.42 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $348,668,000.00 |
| Revenue This Year | N/A | $8.03 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.86 |
| 52 Week Low | $2.32 | $5.32 |
| 52 Week High | $2.63 | $9.13 |
Technical Indicators
Market Signals| Indicator | DHF | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 47.64 | 28.11 |
| Support Level | $2.32 | $5.34 |
| Resistance Level | $2.43 | $6.71 |
| Average True Range (ATR) | 0.03 | 0.13 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 25.00 | 5.57 |
Price Performance
Historical ComparisonAbout DHF BNY Mellon High Yield Strategies Fund
BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. The fund invests predominantly in fixed-income securities of below-investment-grade credit quality.
About INGN Inogen Inc
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.